Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07297394

Mechanisms of Maternal Immune Tolerance in Early Pregnancy

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study explores the mechanisms of maternal immune tolerance in early pregnancy by characterizing immune cell profiles and functional pathways during the first trimester. The goal is to identify immunological factors that support healthy gestation and prevent complications such as miscarriages.

Detailed description

Maternal immune tolerance is essential for a successful pregnancy, as the maternal immune system must accept the semi-allogeneic fetus while maintaining defense against pathogens. Failure in this delicate balance can lead to complications such as recurrent miscarriage, preeclampsia, or implantation failure. Although several immune cell types, including T cells and regulatory pathways, are thought to play a role, the precise mechanisms underlying maternal immune adaptation during early pregnancy remain poorly understood. This observational study investigates immunological changes occurring before and during early pregnancy and miscarriage in women undergoing in vitro fertilization (IVF). Blood samples will be collected at multiple predefined time points: prior to embryo transfer and during the first trimester of pregnancy as well as after miscarriage. These samples will be analyzed for immune cell composition, activation status, and cytokine profiles using advanced immunological assays. The longitudinal design allows for tracking dynamic changes in immune regulation from pre-implantation through early gestation. The primary objective is to identify cellular and molecular signatures associated with maternal immune tolerance and successful implantation. Insights gained from this study may inform future strategies to predict and prevent pregnancy complications such as early miscarriage related to immune dysregulation.

Conditions

Interventions

TypeNameDescription
OTHERBlood samplingBlood samples will be analyzed before and during early pregnancy as well as after early miscarriage

Timeline

Start date
2026-03-02
Primary completion
2030-12-01
Completion
2030-12-01
First posted
2025-12-22
Last updated
2026-03-04

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT07297394. Inclusion in this directory is not an endorsement.